Brief Profile

Diss Brief Profile

The Brief Profile summarizes the non-confidential data on substances as it is held in the databases of the European Chemicals Agency (ECHA), including data provided by third parties. The Brief Profile is automatically generated; note that it does not currently distinguish between harmonised classification and minimum classification; information requirements under different legislative frameworks may therefore not be fully up to date or complete. For accuracy reasons, substance manufacturers and imports have the responsibility to consult official sources, e.g. the electronic edition of the Official Journal of the European Union.
This Brief Profile is covered by the ECHA Legal Notice.

Substance Description

Substance identity

  • EC / List name:
  • IUPAC name: pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
  • Substance names and other identifiers
EC / List no.:
419-210-2
CAS no.:
178452-71-6
Index number:
611-132-00-9
Molecular formula:
C66H48CrN16Na5O28S6
SMILES:
[Na+].[Na+].[Na+].[Na+].[Na+].[Cr+3].CCCCN1C(O)=C(N=NC2=CC=C(C=C2)S(=O)(=O)NC2=CC3=C([O-])C(N=NC4=C([O-])C(=CC(=C4)N(=O)=O)S([O-])(=O)=O)=C(C=C3C=C2)S([O-])(=O)=O)C(C)=C(C#N)C1=O.CCCCN1C(O)=C(N=NC2=CC=C(C=C2)S(=O)(=O)NC2=CC3=C([O-])C(N=NC4=C([O-])C(=CC(=C4)N(=O)=O)S([O-])(=O)=O)=C(C=C3C=C2)S([O-])(=O)=O)C(C)=C(C#N)C1=O
InChI:
InChI=1S/2C33H28N8O14S3.Cr.5Na/c2*1-3-4-11-40-32(44)24(16-34)17(2)28(33(40)45)37-35-19-7-9-22(10-8-19)56(48,49)39-20-6-5-18-12-26(57(50,51)52)29(30(42)23(18)13-20)38-36-25-14-21(41(46)47)15-27(31(25)43)58(53,54)55;;;;;;/h2*5-10,12-15,39,42-43,45H,3-4,11H2,1-2H3,(H,50,51,52)(H,53,54,55);;;;;;/q;;+3;5*+1/p-8
Type of substance:
Mono constituent substance
Origin:
Other
Registered compositions:
3
Of which contain:
0 impurities relevant for classification
0 additives relevant for classification
Substance Listed:
ELINCS (European LIst of Notified Chemical Substances) List

Hazard classification & labelling

Danger! According to the harmonised classification and labelling (CLP00) approved by the European Union, this substance causes serious eye damage and is harmful to aquatic life with long lasting effects.

Breakdown of all 66 C&L notifications submitted to ECHA

Eye Dam. 1 H318 Harmonised Classification
Aquatic Chronic 3 H412 Harmonised Classification
Not Classified
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/tick.png Harmonised Classification

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/Reach.png REACH registration dossiers notifications

https://www.echa.europa.eu/o/diss-blank-theme/images/cnl/graph/CLP.png CLP notifications

Properties of concern

Regulatory context

Registration, Evaluation, Authorisation & Restriction of Chemicals (REACH)

Registration
Pre-registration:
Substance pre-registered under REACH.
Registration:
This substance has 2 active registrations under REACH, 1 Joint Submission(s) and 1 Individual Submission(s).
Please see Registrants/Suppliers details.
Evaluation
Dossier Evaluation:
Substance Evaluation:
Authorisation
Candidate List:
Annex XIV (Authorisation List):
Restriction
Annex XVII (Restriction List):

Persistent Organic Pollutants Regulation (POPs)

List of substances subject to the POPs Regulation:
List of substances proposed as POPs:

Classification Labelling & Packaging (CLP)

Harmonised C&L:
A European Union Harmonised Classification & Labelling has been assigned to this substance.
Seveso Annex I:
Notified C&L:
Classification & Labelling has been notified by industry to ECHA for this substance.

Biocidal Products Regulation (BPR)

Active Substance:
Biocidal Products:

Prior Informed Consent (PIC)

Annex I:
Annex V:

European Union Observatory for Nanomaterials (EUON)

EUON:

About this substance

This substance is registered under the REACH Regulation and is manufactured in and / or imported to the European Economic Area, at ≥ 1 tonnes per annum.

This substance is used in articles, by professional workers (widespread uses), in formulation or re-packing, at industrial sites and in manufacturing.

ECHA has no public registered data indicating whether or in which chemical products the substance might be used.

ECHA has no public registered data on the routes by which this substance is most likely to be released to the environment.

This substance is used in the following activities or processes at workplace: the low energy manipulation of substances bound in materials or articles and high energy work-up of substances bound in materials or articles (e.g. hot rolling/forming, grinding, mechanical cutting, drilling or sanding).

Release to the environment of this substance can occur from industrial use: industrial abrasion processing with low release rate (e.g. cutting of textile, cutting, machining or grinding of metal). Other release to the environment of this substance is likely to occur from: indoor use in long-life materials with low release rate (e.g. flooring, furniture, toys, construction materials, curtains, foot-wear, leather products, paper and cardboard products, electronic equipment) and outdoor use in long-life materials with low release rate (e.g. metal, wooden and plastic construction and building materials).

This substance can be found in products with material based on: fabrics, textiles and apparel (e.g. clothing, mattress, curtains or carpets, textile toys), leather (e.g. gloves, shoes, purses, furniture) and paper (e.g. tissues, feminine hygiene products, nappies, books, magazines, wallpaper).

This substance is used in the following products: textile treatment products and dyes.

This substance is used for the manufacture of: textile, leather or fur.

This substance is used in the following activities or processes at workplace: treatment of articles by dipping and pouring.

Other release to the environment of this substance is likely to occur from: indoor use.

This substance is used in the following products: inks and toners, leather treatment products, paper chemicals and dyes, polymers and textile treatment products and dyes.

This substance is used in the following activities or processes at workplace: mixing in open batch processes, transfer of chemicals at dedicated facilities, transfer of substance into small containers and laboratory work.

Release to the environment of this substance can occur from industrial use: formulation of mixtures.

This substance is used in the following products: paper chemicals and dyes, inks and toners, leather treatment products, polymers and textile treatment products and dyes.

This substance is used in the following areas: printing and recorded media reproduction. This substance is used for the manufacture of: textile, leather or fur, pulp, paper and paper products, wood and wood products and plastic products.

This substance is used in the following activities or processes at workplace: transfer of chemicals at dedicated facilities, transfer of substance into small containers, closed, continuous processes with occasional controlled exposure, mixing in open batch processes, calendering operations, industrial spraying, roller or brushing applications and treatment of articles by dipping and pouring.

Release to the environment of this substance can occur from industrial use: in the production of articles.

This substance is used in the following activities or processes at workplace: closed batch processing in synthesis or formulation, batch processing in synthesis or formulation with opportunity for exposure, transfer of chemicals at dedicated facilities, transfer of substance into small containers and laboratory work.

Release to the environment of this substance can occur from industrial use: manufacturing of the substance.

ECHA has no data from registration dossiers on the precautionary measures for using this substance. Guidance on the safe use of the substance provided by manufacturers and importers of this substance.

Registrants/suppliers

  • ARCHROMA IBÉRICA, S.L., ZAL-Prat c/Cal Coracero, 46-56 08820 El Prat de Llobregat Spain
  • Stahl Europe B.V., Sluisweg 10 5145PE Waalwijk Noord Brabant Netherlands

Substance names and other identifiers

Chromate(5-), bis(6-(((4-((1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)azo)phenyl)sulfonyl)amino)-4-hydroxy-3-((2-hydroxy-5-nitro-3-sulfophenyl)azo)-2-naphthalenesulfonato(4-))-, pentasodium
OLIVE-GREEN JB 1170
Other
Chromate(5-), bis(6-(((4-(2-(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)diazenyl)phenyl)sulfonyl)amino)-4-(hydroxy-kappaO)-3-(2-(2-(hydroxy-kappaO)-5-nitro-3-sulfophenyl)diazenyl)-2-naphthalenesulfonato(4-))-, sodium (1:5)
OLIVE-GREEN JB 1170
Other
Pentasodium bis(7-(4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino)-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato) chromate (III)
OLIVE-GREEN JB 1170
Other
Pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
EC Inventory, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
OLIVE-GREEN JB 1170
REACH pre-registration, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
Pentasodium bis{7-[[]4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
OLIVE-GREEN JB 1170
Other
pentasodium bis{}{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato}} chromate (III)
OLIVE-GREEN JB 1170
C&L Inventory
bis(6-{4-[(1-butyl-5-kyano-4-metyl-2-oxido-6-oxo-1H-3-pyridyl)diazenyl]benzénsulfónamido}-3-(5-nitro-2-oxido-3-sulfonátofenyldiazenyl)-4-oxidonaftalén-2-sulfonáto)chromitan pentasodný (sk)
C&L Inventory
bis(7-{4-[(1-butyl-2-hydroxy-5-kyan-4-methyl-6-oxo-1,6-dihydro-3-pyridyl)azo]benzen-1-sulfonamido}-5'-nitro-3,3'-disulfonatonaftalen-2-azobenzen-1,2'-diolato)chromitan pentasodný (cs)
C&L Inventory
bis{7-[4-(1-butil-5-ciano-1,2-di-hidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)fenilsulfonilamino]-5'-nitro-3,3'-dissulfonatonaftaleno-2-azobenzeno-1,2'-diolato} cromato (III) de pentassódio (pt)
C&L Inventory
bis{7-[4-(1-butil-5-ciano-1,2-di-hidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)fenilsulfonilamino]-5'-nitro-3,3'-disulfonatonaftaleno-2-azobenceno-1,2'-diolato} cromato (III) de pentasodio (es)
C&L Inventory
bis{7-[4-(1-butil-5-ciano-1,2-diidro-2-idrossi-4-metil-6-osso-3-piridilazo)fenilsolfonilammino]-5'-nitro-3,3'-disolfonatonaftalen-2-azobenzene-1,2'-diolato} cromato(III) pentasodico (it)
C&L Inventory
bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-méthyl-6-oxo-3-pyridylazo)phénylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphtalène-2-azobenzène-1,2'-diolato} chromate (III) de pentasodium (fr)
C&L Inventory
bis{7-[4-(1-butylo-5-cyjano-1,2-dihydro--2-hydroksy-4-metylo-6-okso-3-pirydylo-azo)fenylosulfonyloamino]-5'-nitro--3,3'-disulfonianonaftaleno-2-azo-benzeno-1,2'-diolano}chromian(III) pentasodu (pl)
C&L Inventory
pentanaatriumbis{}{7-[4-(1-butüül-5-tsüano-1,2-dihüdro-2-hüdroksü-4-metüül-6-okso-3-püridüülaso)fenüülsulfonüülamino]-5’-nitro-3,3’-disulfonatonaftaleen-2-asobenseen-1,2’-diolato}kromaat (III) (et)
C&L Inventory
pentanatrijev bis{7-[4-(1-butil-5-ciano-1,2-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)fenilsulfonilamino]-5'-nitro-3,3'-disulfonatonaftalen-2-azobenzen-1,2'-diolato} kromat(III) (hr)
C&L Inventory
pentanatrijev bis{7-[4-(1-butil-5-ciano-1,2-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)fenilsulfonilamino]-5'-nitro-3,3'-disulfonatonaftalen-2-azobenzen-1,2'-diolato}kromat(III) (sl)
C&L Inventory
pentanatrio bis{7-[4-(1-butil-5-cian-1,2-dihidro-2-hidroksi-4-metil-6-okso-3-piridilazo)fenilsulfonilamino]-5′-nitro-3,3′-disulfonatonaftalen-2-azobenzen-1,2′-diolato} chromatas (III) (lt)
C&L Inventory
pentanatrium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)fenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaftaleen-2-azobenzeen-1,2'-diolato} chromaat (III) (nl)
C&L Inventory
pentanatrium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalen-2-azobenzen-1,2'-diolato} chromat (III) (da)
C&L Inventory
Pentanatrium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalin-2-azobenzol-1,2'-diolato} chromat (III) (de)
C&L Inventory
pentanatriumbis-{7-[4-(1-butyl-5-cyan-1,2-dihydro-2-hydroxi-4-metyl-6-oxo-3-pyridylazo)fenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaftalen-2-azobenzen-1,2'-diolat}kromat(III) (sv)
C&L Inventory
pentanatriumbis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroksy-4-metyl-6-okso-3-pyridylazo)fenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaftalen-2-azobenzen-1,2'-diolato}kromat(III) (no)
C&L Inventory
pentanatriumbis{7-[4-(1-butyyli-5-syano-1,2-dihydro-2-hydroksi-4-metyyli-6-okso-3-pyridyyliatso)fenyylisulfonyyliamino]-5'-nitro-3,3'-disulfonaattonaftaleeni-2-atsobentseeni-1,2'-diolaatto}kromaatti (III) (fi)
C&L Inventory
pentanátrium-bisz{7-[4-(1-butil-5-ciano-1,2-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)fenilszulfonilamino]-5’-nitro-3,3’-diszulfonátonaftalin-2-azobenzol-1,2’-dioláto}-kromát(III) (hu)
C&L Inventory
pentanātrija bis-{7-[4-(1-butil-5-ciano-1,2-dihidro-2-hidroksi-4-metil-6-okso-3-piridlazo)fenilsulfonilamino]-5′-nitro-3,3′-disulfonātnaftalēn-2-azobenzol-1,2′-diolāt} hromāts (III) (lv)
C&L Inventory
pentasodiu bis{}{7-[4-(1-butil-5-ciano-1,2-dihidro-2-hidroxi-4-metil-6-oxo-3-piridilazo)fenilsulfonilamino]-5'-nitro-3,3'-disulfonatonaftalen-2-azobenzen-1,2'-diolato}} cromat (III) (ro)
C&L Inventory
δις{7-[4-(1-βoυτυλo-5-κυανo-1,2-διυδρo-2-υδρoξυ-4-μεθυλo-6-oξo-3-πυριδυλαζω)φαινυλoσoυλφoνυλαμινo]-5΄-νιτρo-3,3΄-δισoυλφoνικoναφθαλινo-2-αζωβενζoλo-1,2΄-διoλικo}χρωμικό (III) πεντανάτριo (el)
C&L Inventory
пентанатриев бис{7-[4-(1-бутил-5-циано-1,2-дихидро-2-хидрокси-4-метил-6-оксо-3-пиридилазо)фенилсулфониламино]-5′-нитро-3,3′-дисулфонатонафтален-2-азобензен-1,2′-диoлато}хромат (III) (bg)
C&L Inventory
Chromate(5-), bis[6-[[[4-[2-(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)diazenyl]phenyl]sulfonyl]amino]-4-(hydroxy-.kappa.O)-3-[2-[2-(hydroxy-.kappa.O)-5-nitro-3-sulfophenyl]diazenyl]-2-naphthalenesulfonato(4-)]-, sodium (1:5)
Other
Chromate(5-), bis[6-[[[4-[2-(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)diazenyl]phenyl]sulfonyl]amino]-4-(hydroxy-κO)-3-[2-[2-(hydroxy-κO)-5-nitro-3-sulfophenyl]diazenyl]-2-naphthalenesulfonato(4-)]-, sodium (1:5)
Registration dossier
chromium(3+) pentasodium bis(7-{4-[2-(1-butyl-5-cyano-2-hydroxy-4-methyl-6-oxo-1,6-dihydropyridin-3-yl)diazen-1-yl]benzenesulfonamido}-2-[2-(5-nitro-2-oxido-3-sulfophenyl)diazen-1-yl]-3-sulfonaphthalen-1-olate)
Other
Olive-Green JB 1170
C&L Inventory
pentasodium bis{7-[4-(1-butyl-5-cyano-1,2-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)phenylsulfonylamino]-5'-nitro-3,3'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato} chromate (III)
C&L Inventory
178452-71-6
CAS number
C&L Inventory, Registration dossier, Other, CAD - Chemical Agents Directive, Art. 2(b)(i) - Hazardous Agents, Construction Product Regulation - Annex I (3) - Hazardous Substances, Construction Product Regulation - Art. 6(5) - SDS and Declaration, EU Ecolabels - Restrictions for Hazardous Substances/Mixtures, End-of-Life Vehicles Directive - Hazardous Substances, Active Implantable Medical Devices Directive - Hazardous Substances, In Vitro Diagnostic Medical Devices Directive - Hazardous Substances, Marine Environmental Policy Framework Directive - Hazardous Substances, Medical Devices Directive - Hazardous Substances, General Product Safety Directive - Hazardous Substances, Workplace Signs - minimum requirements & signs on containers and pipes, Safety and Health of Workers at Work Directive - Hazardous Substances, Waste Framework Directive, Annex III - Waste - Hazardous Properties
611-132-00-9
Index number
C&L Inventory

Scientific properties

Physical and chemical properties

This section provides physicochemical information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Appearance/physical state / colour

Study results
  • 3 studies submitted
  • 2 studies processed
C Physical state at 20°C and 1013 hPa
Solid (100%) [2]
C Form
Solid: particulate/powder (100%) [1]
C Odour
Odourless (100%) [1]

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence 1 1
Other 1
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Physical state at 20°C and 1013 hPa
Solid (100%)

Melting/freezing point

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Boiling point

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Density

Study results
  • 1 study submitted
  • 1 study processed
R Relative density
1.58 @ 22.5 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Relative density at 20°C
1.58

Vapour pressure

Study results
  • 2 studies submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study 1
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
R Summaries
  • 1 summary submitted
  • 1 summary processed
Vapour pressure
0 Pa @ 25 °C

Partition coefficient

Study results
  • 1 study submitted
  • 1 study processed
R Log Pow
-2 [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Log Kow (Log Pow)
-2

Water solubility

Study results
  • 1 study submitted
  • 1 study processed
R Water solubility (mass/vol.)
400 g/L @ 20 °C and pH 6 [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Water solubility
400 g/L @ 20 °C

Solubility in organic solvents / fat solubility

Data not provided by the registrant

Surface tension

Study results
  • 1 study submitted
  • 1 study processed
R Surface tension
49.1 mN/m @ 1.05 g/L and 21 °C [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Surface tension at 20 °C
49.1 mN/m @ 1 050 mg/L

Flash point

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
Not feasible 1
Sci. unjustified
Exposure cons.
Other
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Auto flammability

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Autoflammability / self-ignition at 101 325 Pa
278 °C

Flammability

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Flammability
Not classified (100%)

Explosiveness

Study results
  • 1 study submitted
  • 1 study processed
C Interpretation of results
Other: (100%) [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Explosiveness
Non-explosive (100%)

Oxidising

Study results
  • 1 study submitted
  • 0 studies processed

No automatically processable data submitted

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Oxidising
Non oxidising (100%)

Oxidation reduction potential

Data not provided by the registrant

pH

Data not provided by the registrant

Dissociation constant

Data not provided by the registrant

Viscosity

Data not provided by the registrant

Environmental fate and pathways

This section provides environmental fate and pathways information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Phototransformation in air

Data not provided by the registrant

Hydrolysis

Study results
  • 1 study submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
Half-life for hydrolysis
1.8 years @ 25 °C

Phototransformation in water

Data not provided by the registrant

Phototransformation in soil

Data not provided by the registrant

Biodegradation in water - screening tests

Study results
  • 1 study submitted
  • 1 study processed
C Interpretation of results
Not readily biodegradable (100%) [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
C Summaries
  • 1 summary submitted
  • 1 summary processed
Biodegradation in water
Under test conditions no biodegradation observed (100%)

Biodegradation in water & sediment - simulation tests

Data not provided by the registrant

Biodegradation in soil

Data not provided by the registrant

Bioaccumulation: aquatic / sediment

Data not provided by the registrant

Bioaccumulation: terrestrial

Data not provided by the registrant

Adsorption/desorption

Data not provided by the registrant

Henrys law constant (H)

Data not provided by the registrant

Distribution modelling

Data not provided by the registrant

Ecotoxicological information

This section provides ecotoxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Predicted No-Effect Concentration (PNEC)

Data not provided by the registrant

Short–term toxicity to fish

Study results
  • 1 study submitted
  • 1 study processed
P/RResults
LC50 (4 days) 54 mg/L [1]
LC0 (4 days) 21 mg/L [1]
LC100 (4 days) 100 mg/L [1]
NOEC (4 days) 21 mg/L [1]
LOEC (4 days) 46 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Long–term toxicity to fish

Data not provided by the registrant

Short–term toxicity to aquatic invertebrates

Study results
  • 1 study submitted
  • 1 study processed
P/RResults
EC50 (48 h) 62 mg/L [1]
EC50 (24 h) 100 mg/L [1]
EC0 (48 h) 10 mg/L [1]
EC100 (48 h) 100 mg/L [1]
NOEC (48 h) 10 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Long–term toxicity to aquatic invertebrates

Data not provided by the registrant

Toxicity to aquatic algae and cyanobacteria

Study results
  • 1 study submitted
  • 1 study processed
P/RResults
EC50 (72 h) 100 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
EC50 for freshwater algae
100 mg/L

Toxicity to aquatic plants other than algae

Data not provided by the registrant

Toxicity to microorganisms

Study results
  • 1 study submitted
  • 1 study processed
P/RResults
EC50 (3 h) 100 mg/L [1]

Type of Study provided
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
R Summaries
  • 1 summary submitted
  • 1 summary processed
EC50 for microorganisms
100 mg/L

Sediment toxicity

Data not provided by the registrant

Endocrine disrupter testing in aquatic vertebrates – in vivo

Data not provided by the registrant

Toxicity to terrestrial macroorganisms except arthropods

Data not provided by the registrant

Toxicity to terrestrial arthropods

Data not provided by the registrant

Toxicity to terrestrial plants

Data not provided by the registrant

Toxicity to soil microorganisms

Data not provided by the registrant

Toxicity to birds

Data not provided by the registrant

Toxicity to mammals

Data not provided by the registrant

Toxicological information

This section provides toxicological information compiled from all automatically processable data from REACH registration dossiers that is available to ECHA at the time of generation. The quality and correctness of the information remains the responsibility of the data submitter. The Agency thus cannot guarantee the correctness of the information displayed.

Derived No- or Minimal Effect Level (DN(M)EL)

Data not provided by the registrant

Toxicokinetics, metabolism, and distribution

Study results
Study data: basic toxicokinetics
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: basic toxicokinetics
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal absorption
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: dermal absorption
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Summaries
  • 1 summary submitted
  • 0 summaries processed

No automatically processable data submitted

Acute toxicity

Study results
oral
  • 1 study submitted
  • 1 study processed
P/RResults
LD50 2 000 mg/kg bw (rat) [1]
M/CInterpretations of results
Other [1]

Type of Study provided
oral
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
dermal
  • 1 study submitted
  • 1 study processed
P/RResults
LD50 2 000 mg/kg bw (rat) [1]
M/CInterpretations of results
Other [1]

dermal
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
other routes
  • 0 studies submitted
  • 0 studies processed

No data available

other routes
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Oral route:
No adverse effect observed LD50 2 000 mg/kg bw
Dermal route:
No adverse effect observed LD50 2 000 mg/kg bw

Irritation / corrosion

Study results
Study data: skin
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: eye
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: eye
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Skin
No adverse effect observed (not irritating)
Eye
Adverse effect observed (irreversible damage)
Respiratory
No study available

Sensitisation

Study results
Study data: skin
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: skin
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
Not feasible
Sci. unjustified 1
Exposure cons.
Other
Study data: respiratory
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: respiratory
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Skin sensitisation
No adverse effect observed (not sensitising)
Respiratory sensitisation
No study available

Repeated dose toxicity

Study results
Study data: oral
  • 1 study submitted
  • 1 study processed
P/RResults
NOAEL (rat): 200 mg/kg bw/day [1]

Type of Study provided
Study data: oral
Studies with data
Key study 1
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: inhalation
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: inhalation
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: dermal
  • 0 studies submitted
  • 0 studies processed

No data available

Study data: dermal
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Oral route - systemic effects:
Adverse effect observed NOAEL 200 mg/kg bw/day (subacute, rat)

Genetic toxicity

Study results
Study data: in vitro
  • 2 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Type of Study provided
Study data: in vitro
Studies with data
Key study 2
Supporting study
Weight of evidence
Other
Data waiving
no waivers
Study data: in vivo
  • 0 studies submitted
  • 0 studies processed

Study data not processed for brief profile

Study data: in vivo
Studies with data
Key study
Supporting study
Weight of evidence
Other
Data waiving
no waivers
M/C Summaries
  • 1 summary submitted
  • 1 summary processed
Toxicity - InVitro
No adverse effect observed (negative)
Toxicity - InVivo
No study available

Carcinogenicity

Data not provided by the registrant

Toxicity to reproduction

Data not provided by the registrant

Neurotoxicity

Data not provided by the registrant

Immunotoxicity

Data not provided by the registrant

Endocrine disrupter mammalian screening - in vivo

Data not provided by the registrant